CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment

Journal: Journal of Clinical Investigation

Published: 2020-03-02

DOI: 10.1172/jci128895

Affiliations: 12

Authors: 22

Go to article
Institutions Share
Department of Oncology-Pathology, KI, Sweden 0.41
Cell Therapy Institute, Nova Southeastern University, United States of America (USA) 0.14
Department of Medical Epidemiology and Biostatistics (MEB), KI, Sweden 0.09
Department of Medicine, Huddinge (MEDH), KI, Sweden 0.09
Department of Microbiology, Tumor and Cell Biology (MTC), KI, Sweden 0.05
Basic Sciences Division, FHCRC, United States of America (USA) 0.05
NIH National Heart, Lung, and Blood Institute (NHLBI), United States of America (USA) 0.05
Glactone Pharma AB, Sweden 0.05
Second Affiliated Hospital of Zhejiang University (SAHZU), ZJU, China 0.02
Department of Molecular Medicine and Surgery (MMK), KI, Sweden 0.02
Capio St. Goran’s Hospital, Sweden 0.02
Department of Laboratory Medicine, KI, Sweden 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER